Skip to main content
Premium Trial:

Request an Annual Quote

Lion s Revenues Tumble 65 Percent as Losses Narrow in Fiscal Q3; Restructuring Ongoing

NEW YORK, Feb. 3 (GenomeWeb News) - Lion Bioscience reported sharply reduced revenues "in line with expectations," as well as reduced losses for its third fiscal quarter today.


Total revenues for the three months ended Dec. 31, 2004, fell 65 percent to €2.2 million ($2.9 million) from €6.3 million during the same period a year ago.


Lion did not break out its R&D costs for the quarter.


The company's net loss for the quarter fell by roughly half, to €3.2 million from €6.3 million during the same quarter last year.


As of Dec. 31, Lion had €29.5 million in liquid assets.


As of Dec. 22, Lion's delisting of its American Depositary Share from Nasdaq and termination of its American Depositary Receipt facility has been effective. ADR holders can now surrender their ADS's in common shares, traded on the German stock exchange, until Feb. 20. After that date, JPMorgan will sell the underlying common shares for Lion ADS's that have not been surrendered to the extent possible on the German stock market.


Lion said it aims to become profitable in fiscal year 2004/2005, which starts April 1. The company plans to "be focused solely on profitable activities" and seeks to "have an optimized organizational structure," according to a company statement.


Lion said it expects to publish more details on its restructuring effort "in the near future."

The Scan

International Team Proposes Checklist for Returning Genomic Research Results

Researchers in the European Journal of Human Genetics present a checklist to guide the return of genomic research results to study participants.

Study Presents New Insights Into How Cancer Cells Overcome Telomere Shortening

Researchers report in Nucleic Acids Research that ATRX-deficient cancer cells have increased activity of the alternative lengthening of telomeres pathway.

Researchers Link Telomere Length With Alzheimer's Disease

Within UK Biobank participants, longer leukocyte telomere length is associated with a reduced risk of dementia, according to a new study in PLOS One.

Nucleotide Base Detected on Near-Earth Asteroid

Among other intriguing compounds, researchers find the nucleotide uracil, a component of RNA sequences, in samples collected from the near-Earth asteroid Ryugu, as they report in Nature Communications.